All Stories

  1. Biomarkers in Heart Failure and Associated Diseases
  2. Sex-Specific Cut-Offs for High-Sensitivity Cardiac Troponin: Is Less More?
  3. Update on Extended Treatment for Venous Thromboembolism
  4. Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
  5. Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
  6. Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation
  7. Association Between Peripheral Artery Disease and Incident Risk of Atrial Fibrillation: Strong Evidence Coming From Population‐Based Cohort Studies
  8. Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry
  9. Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
  10. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial
  11. Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial
  12. Edoxaban in venous thromboembolism and stroke prevention: an appraisal
  13. Ankle-Brachial Index and cardiovascular events in atrial fibrillation
  14. Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
  15. Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For Women
  16. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
  17. GW26-e2301 The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis
  18. Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation
  19. The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis
  20. Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes
  21. Antidotes to non-vitamin K oral anticoagulants: necessary or not?
  22. Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS study
  23. Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study
  24. Non-steroidal anti-inflammatory drugs and incident atrial fibrillation
  25. Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT 2 R 2 score
  26. LexMeter: Validation of an Automated System for the Assessment of Lexical Competence of Medical Students as a Prerequisite for the Development of an Adaptive e-learning System
  27. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type
  28. Impact of Sex and Gender on the Efficacy of Antiplatelet Therapy: The Female Perspective
  29. Erratum to: Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study
  30. Asymptomatic peripheral artery disease and antiplatelet management
  31. Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study
  32. Reply
  33. Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation
  34. Role of platelets in NOX2 activation mediated by TNFα in heart failure
  35. VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension
  36. Ascorbic Acid Infusion Blunts CD40L Upregulation in Patients Undergoing Coronary Stent